Nuisance Bleeding With Prolonged Dual Antiplatelet Therapy After Acute Myocardial Infarction and its Impact on Health Status-Reference-Cited by-同舟云学术

Nuisance Bleeding With Prolonged Dual Antiplatelet Therapy After Acute Myocardial Infarction and its Impact on Health Status

Published:2013-05 Issue:21 Volume:61 Page:2130-2138
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Amin Amit P.,Bachuwar Alok,Reid Kimberly J.,Chhatriwalla Adnan K.,Salisbury Adam C.,Yeh Robert W.,Kosiborod Mikhail,Wang Tracy Y.,Alexander Karen P.,Gosch Kensey,Cohen David J.,Spertus John A.,Bach Richard G.

Funder

National Heart, Lung, and Blood Institute

National Center for Advancing Translational Sciences of the National Institutes of Health

National Cancer Institute of the National Institutes of Health

Medtronic Minimed

Gilead Sciences

Genentech

Sanofi-Aventis

GluMetrics Inc.

Bristol-Myers Squibb

Daiichi Sankyo

Heartscape Technologies

Eli Lilly & Company

Schering Plough/Merck

Gilead

Boston Scientific

Medtronic

Abbott Vascular

Eli Lilly

Daichi Sankyo

Accumetrix

BMS/Sanofi

Schering-Plough

AstraZeneca

Edwards Lifesciences

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)

2. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events;Bhatt;N Engl J Med,2006

3. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease;Squizzato;Cochrane Database Syst Rev,2011

4. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial;Steinhubl;JAMA,2002

5. Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI?;Widimsky;Eur Heart J,2008

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis;HEALTH TECHNOL ASSES;2024

2. Flow diverter surface modifications for aneurysm treatment: A review of the mechanisms and data behind existing technologies;Interventional Neuroradiology;2023-10-29

3. Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry;Open Heart;2023-08

4. De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis;Nature Reviews Cardiology;2023-07-20

5. Ticagrelor is related to nuisance bleeding after flow diversion of unruptured intracranial aneurysms;Neurosurgical Review;2023-06-03